Skip to content

IQSM · ARCA · ETF

NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) Price, Holdings & Fees

$676.19−0.13%−$0.90End-of-day price as of Oct 9, 2026

NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) closed at $676.19 on Oct 9, 2026, down 0.13% from the previous close of $677.09.

Share price, past year

1Y +26.42%

52-week range $532.42 – $694.20. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$676.19
Sep 30, 2026$685.35
Aug 31, 2026$663.01
Jul 31, 2026$625.67
Jun 30, 2026$596.95
May 29, 2026$612.59
Apr 30, 2026$620.22
Mar 31, 2026$585.72
Feb 27, 2026$554.92
Jan 30, 2026$563.49
Dec 31, 2025$575.32
Nov 28, 2025$577.68
Oct 31, 2025$558.34

Key statistics

Expense ratio
0.15%
as of Aug 31, 2025
Net assets
$329.7M
as of Jul 31, 2026
Holdings
248
as of Jul 31, 2026
52-week range
$532.42 – $694.20

NYLIM Candriam U.S. Mid Cap Equity ETF's expense ratio is 0.15%: $15.00 a year on $10,000 invested.

Holdings

NYLIM Candriam U.S. Mid Cap Equity ETF held 248 investments worth $329.72M as of Jul 31, 2026. Its largest holding was REVOLUTION MEDICINES INC, at 1.32% of the fund.

NYLIM Candriam U.S. Mid Cap Equity ETF largest holdings by share of net assets
#Holding% of fundValue
1REVOLUTION MEDICINES INCRVMD1.32%$4.34M
2TWILIO INCTWLO1.01%$3.32M
3NVENT ELECTRIC PLCNVT0.93%$3.07M
4BURLINGTON STORES INCBURL0.93%$3.06M
5US FOODS HOLDING CORPUSFD0.92%$3.02M
6OKTA INCOKTA0.90%$2.97M
7F5 INCFFIV0.88%$2.89M
8GUARDANT HEALTH INCGH0.83%$2.73M
9VIATRIS INCVTRS0.78%$2.57M
10MKS INCMKSI0.76%$2.50M
11MODERNA INCMRNA0.71%$2.34M
12ROKU INCROKU0.71%$2.32M
13TD SYNNEX CORPSNX0.71%$2.32M
14BALL CORPBALL0.69%$2.27M
15KIMCO REALTY CORPKIM0.68%$2.25M
16CH ROBINSON WORLDWIDE INCCHRW0.68%$2.24M
17IDEX CORPIEX0.67%$2.20M
18BEST BUY CO INCBBY0.66%$2.18M
19YUM CHINA HOLDINGS INCYUMC0.66%$2.16M
20JONES LANG LASALLE INCJLL0.65%$2.16M
21HOST HOTELS & RESORTS INCHST0.65%$2.13M
22ANNALY CAPITAL MANAGEMENT INCNLY0.64%$2.11M
23LATTICE SEMICONDUCTOR CORPLSCC0.64%$2.11M
24W.P. CAREY INCWPC0.64%$2.10M
25NEUROCRINE BIOSCIENCES INCNBIX0.63%$2.09M

Top 25 of 248 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.

What the fund owns

NYLIM Candriam U.S. Mid Cap Equity ETF holdings by asset type
Asset type% of fund
Stocks99.88%
Cash and short-term investments0.28%
NYLIM Candriam U.S. Mid Cap Equity ETF holdings by country, largest 8
Country% of fund
United States93.77%
Ireland2.47%
Bermuda2.25%
Jersey0.44%
Puerto Rico0.44%
Luxembourg0.37%
United Kingdom0.22%
Canada0.18%

Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.

Monthly total returns

Over the 3 months to Jul 31, 2026, NYLIM Candriam U.S. Mid Cap Equity ETF's total return was +5.55%, as reported to the SEC.

NYLIM Candriam U.S. Mid Cap Equity ETF monthly total returns
MonthTotal return
Jul 31, 2026−1.53%
Jun 30, 2026+4.00%
May 31, 2026+3.07%

The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.

Fund profile

Name
NYLIM Candriam U.S. Mid Cap Equity ETF
Ticker
IQSM
Exchange
ARCA
Fund type
ETF
Trust
NYLIM ETF Trust
SEC series ID
S000077598
SEC CIK
0001415995
Fractional shares
Yes

Recent SEC filings

Shareholder reports and prospectuses are filed by NYLIM ETF Trust, the trust behind NYLIM Candriam U.S. Mid Cap Equity ETF, and cover all of its funds.

Frequently asked questions

What is IQSM's price?

NYLIM Candriam U.S. Mid Cap Equity ETF (IQSM) closed at $676.19 on Oct 9, 2026, down 0.13% from the previous close of $677.09.

What is IQSM's expense ratio?

NYLIM Candriam U.S. Mid Cap Equity ETF's expense ratio is 0.15%: $15.00 a year on $10,000 invested.

What does IQSM hold?

NYLIM Candriam U.S. Mid Cap Equity ETF held 248 investments worth $329.72M as of Jul 31, 2026. Its largest holding was REVOLUTION MEDICINES INC, at 1.32% of the fund. Its five largest holdings were REVOLUTION MEDICINES INC, TWILIO INC, NVENT ELECTRIC PLC, BURLINGTON STORES INC, US FOODS HOLDING CORP.

How has IQSM performed?

Over the 3 months to Jul 31, 2026, NYLIM Candriam U.S. Mid Cap Equity ETF's total return was +5.55%, as reported to the SEC.

Sources and methodology

Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 25, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Aug 31, 2025. Prices are generated sample data for development. Data sources and disclosures